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Poly(3-hydroxybutyrate-co-3-hydroxyhexanote) (PHBHHx) belongs to the 
family of polyhydroxyalkanoates and has shown improved ductility and 
biocompatibility over its other members, leading to its increased usage in 
tissue engineering research. However, its ductility can be further enhanced in 
order to widen its range of applications. Therefore, the aim of this thesis was 
to blend PHBHHx with highly ductile medical grade polycaprolactone 
(mPCL), and it was hypothesized that PHBHHx/mPCL blend will show 
improved ductility. Degradation and cytocompatibility studies were also 
conducted. 
PHBHHx/mPCL were blended in seven different proportions (100% 
PHBHHx/0% mPCL, 90% PHBHHx/10% mPCL, 70% PHBHHx/30% mPCL, 
50% PHBHHx/50% mPCL, 30% PHBHHx/70% mPCL, 10% PHBHHx/90% 
mPCL, 0% PHBHHx/100% mPCL), and their mechanical properties were 
characterized using tensile testing. Results indicated that ductility was 
enhanced with the addition of mPCL. More specifically, yield strain was 
improved (0.0819 ± 0.004, p<0.05) and at 30 PHBHHx/ 70 mPCL, high yield 
strength was also achieved. PHBHHx/mPCL blends were immiscible after 
analyzing their thermal properties, with two distinct melting temperatures 
present across all blends. In addition, crystallinity increased with increased 
mPCL. At 30% PHBHHx/70% mPCL, crystallinity (31.7 %) was comparable 
to 0% PHBHHx/100% mPCL (46.6 %). Investigation of its surface 
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morphology using scanning electron microscopy (SEM) led to the conclusion 
that PHBHHx/mPCL were incompatible as each component displayed distinct 
morphologies. Under cross-polarized light, PHBHHx showed a single reddish 
tint while mPCL displayed a multi-colored, characteristic Maltese cross 
pattern which was an indication of the presence of lamellar crystals. Molecular 
weight (Mw) of PHBHHx/mPCL decreased with the addition of mPCL due to 
its lower Mw (117606 ± 694 g/mol). Surface hydrophilicity, which is 
indicative of the effectiveness of cell-biomaterial interaction, improved as the 
amount of mPCL increased. In summary, PHBHHx/mPCL showed improved 
ductility, and 30% PHBHHx/70% mPCL displayed the highest yield strain and 
good yield strength. 
The second part of this thesis investigated the cytocompatibility of non-surface 
treated 100% PHBHHx/0% mPCL, 30% PHBHHx/70% mPCL, and 0% 
PHBHHx/100% mPCL using human fetal mesenchymal stem cells (hfMSCs). 
Qualitative analysis of cell proliferation and morphology under confocal laser 
scanning microscopy (CLSM) over 5 days of culture revealed that hfMSCs 
might have a preference for PHBHHx. Proliferation of hfMSCs on day 3 and 
day 5 were higher on 100% PHBHHx/0% mPCL and 30 PHBHHx/ 70 mPCL. 
This suggested that cytocompatibility was not compromised in 30 PHBHHx/ 
70 mPCL, and the proliferation capacity of 30% PHBHHx/70% mPCL could 
possibly be due to the presence of 30% PHBHHx. 
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The final part of this thesis characterized the degradation properties of 100% 
PHBHHx/0% mPCL, 30% PHBHHx/70% mPCL. Hydrolytic degradation was 
conducted over 14 days in accelerated conditions of 0.5M sodium hydroxide at 
37oC. 30% PHBHHx/70% mPCL showed a slow rate of degradation over the 
first 5 days with a mass loss/surface area of 0.5 ± 0.2 mg/cm2. From SEM, pits 
were observable from day 3, and they increased in quantity, size and depth as 
degradation time increased. Crystallinity and Mw decreased with increase in 
degradation time.  
Consolidating the results in the three parts, 30% PHBHHx/70% mPCL 
displayed higher yield strain and good yield strength, slow initial degradation 
rate, and good cytocompatibility with hfMSCs. As such, 30% PHBHHx/70% 
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Chapter 1: Introduction 
1.1 General background 
Scaffold-based tissue engineering design strategies are important in tissue 
engineering nowadays. According to Martina and Hutmacher [1], there are 
four general categories of materials in scaffold-based tissue engineering. The 
first group consists of: polyglycolides (PGA), polylactides (PLA), poly-d,l-
lactic acid (PDLLA), polycaprolactone (PCL); the second group consists of 
new di- and tri-block polymers which are able to incorporate resorbable 
polymers like PLA, PCL in various arrangements in order to customize 
mechanical and degradation properties; the third group consists of polymers 
that are already approved by regulatory bodies like Food and Drug 
Administration (FDA) and/or are already in clinical trials such as 
polyhydroxyalkanoates; the fourth group consists of biomimetic materials.  
Polymeric scaffolds have been applied to various tissue engineering 
applications. For example, PLA plates and screws have been used in the 
treatment of mandibular condylar process fractures in 2004 [2]. These 
resorbable plates and screws were found to be reliably stable for the treatment 
of such fractures. The usage of biodegradable polymers combined with 
bioactive ceramics has also been reviewed by Rezwan et al.[3]. Our group has 
also done extensive work using polymeric scaffolds for bone tissue 
engineering applications, as shown by the many publications [4-13]. In 
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particular, we have focussed on the development and usage of PCL-tricalcium 
phosphate (TCP) scaffolds for bone tissue engineering, and this has been 
successful thus far.  
Some of the important considerations for the selection of materials for tissue 
engineering applications would be their inherent mechanical properties, 
degradation properties, and the properties at the target site of replacement. 
These will affect the scaffold material choice and design. For example, for 
bone tissue engineering, scaffolds need to have a reasonably high Young’s 
modulus in order to withstand the load at the site of injury. In addition, an 
interconnected porous network would be optimal due to its ability to allow for 
the delivery of nutrients to the cells inside the scaffold to maintain their 
viability. Some of the strategies in designing scaffolds for tissue engineering 
applications, which are dependent on the function of the scaffolds in vivo, 
have been reviewed by Hutmacher [14]. Briefly, the first strategy hinges on 
the precise selection of a material such that its degradation and resorption rate 
matches that of host tissue formation to ensure that the mechanical integrity of 
the scaffold is maintained until the implant is fully remodelled by the host 
tissue. In the second strategy, the degradation and resorption rate of the 
scaffold is designed up to the point where premature bone or cartilage tissue, 
for example, is formed. The mechanical integrity of the scaffold is only 
required up to the point where the engineered tissue is able to mechanically 
support itself.  
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The idea of tailoring the degradation and resorption rate of polymeric 
scaffolds to match that of host tissue regeneration, has led to the development 
of new polymeric materials for tissue engineering applications using a variety 
of techniques for combining desirable properties of different polymeric 
materials, such as solvent blending [15], and melt blending [16]. As such, 
there have been many publications over time focussing on the blending and 
compatibilization of various polymer blends [17-24]. 
1.2 Research objectives 
The aim of this thesis is to investigate and develop poly(3-hydroxybutyrate-
co-3-hydroxyhexanoate)/medical grade polycaprolactone (PHBHHx/mPCL) 
blend for tissue engineering applications using solvent blending with the aim 
of enhancing the mechanical properties and changing its degradation 
properties.  
1.2.1 Specific aims 
1) To investigate the mechanical properties of various solvent cast 
PHBHHx/mPCL blends. 
2) To investigate the cell-material interaction of the various 
PHBHHx/mPCL blends. 
3) To investigate the degradation properties of PHBHHx/mPCL blends 




Chapter 2: Literature review 
2.1 Polymer blending  
It has long been established and recognized that polymer blending is an 
economic way of achieving materials with advantageous properties. 
Rightfully, understanding the interplay between the phases in the blends is 
important in explaining their miscibility, which in turn affects their thermal, 
morphological, and mechanical properties. In 1981, Barlow and Paul [25] 
reviewed the thermodynamics and influence of melt processing conditions of 
miscible and immiscible blends on their physical properties. Utracki [26] has 
also written a well-described book on polymer blends, and the relevant 
information has been summarized and presented in the ensuing sub-sections.  
2.1.1 Thermodynamic understanding  
Gibbs free energy of mixing, ΔGm is a thermodynamic rule that can be used to 
understand the miscibility of polymer blends. This can be represented in the 
form of an equation as listed below: 
∆Gm = ∆Hm − T(∆Smc + ∆Sme ) 
where ΔHm  is the heat of mixing, ∆𝑆𝑚𝑐  is the combined entropy of mixing, and 
∆𝑆𝑚
𝑒  is the excess entropy of mixing. As a general rule of thumb, complete 
miscibility occurs only when both the following conditions are fulfilled: 
ΔGm < 0 and 
∂2∆Gm
∂∅2
2 > 0 
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Representing the free energy of mixing as a function of phase in a binary 
polymer blend as shown in Fig. 1, if can be seen that only curve 3 meets the 
requirements.  
 
Figure 1 Possible ΔGm diagrams for a binary phase polymer blend (Adapted and modified from Barlow 
and Paul [25]) 
2.1.2 Immiscible polymer blends 
In understanding miscible, the thermodynamic requirements have been laid 
down in the previous section. For immiscible blends, Thirta et al. has 
suggested that polymer immiscibility is a result of high molecular weight and 
the consequent entropy constraints [27]. As a result, various techniques have 
been employed to enhance compatibility by modifying interfacial tension, 
such as usage of copolymers or direct modification of interfacial tension. The 
idea of interfacial tension has also been brought up by Anastasiadis et al. in 
1988 [17], in which they emphasized that interfacial tension is important due 
to its influence on the morphology of polymer blends with different phases. 
The interface structure was also mentioned to be influential in determining the 
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mechanical properties of the polymer blend. Despite the influence that 
interfacial tension has on the mechanical properties of immiscible blends, it 
has been suggested that at specific compositions, uncompatibilized immiscible 
blends can lead to, based on the “rule of mixtures behaviour”, synergistic 
effects on properties. Barlow and Paul mentioned that the properties of 
immiscible polymer blends depend on phase morphology and interaction, as 
well as composition [25]. With a controllable phase morphology, which might 
be achievable through precise usage of blending solvents and/or controlled 
solvent evaporation, blended polymers might still have commercial use.  
2.2 Polycaprolactone 
Polycaprolactone (PCL) was one of the earliest polymers to be synthesized by 
the Carothers group [28]. It subsequently became commercially available. 
PCL is a semi-crystalline, aliphatic polymer that has a melting point of about 
60oC. It has a low glass transition temperature (-60oC), which accounts for the 
rubbery state in ambient temperature. This low Tg enhances its processability. 
PCL has shown good solubility and exceptional blend compatibility [29, 30], 
of which the latter was categorized into three types of compatibility, namely: 
exhibiting only a single Tg, being mechanically compatible (exhibiting 
superior mechanical properties despite observable Tg of all components within 
the blend), and showing enhanced properties of phase separated material [21]. 
In addition, PCL has a long degradation life, which makes is appealing for 
long-term drug delivery applications; this application has been prevalent 
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during the 1970s and the 1980s [28]. Despite all these advantages of PCL, 
there was a period of 20 years where it was forgotten, courtesy of the rise of 
biodegradable polymers with high resorption rate (within 2 to 4 months) such 
as polylactides and polyglycolides. At that time, the focus was on drug 
delivery using highly resorbable polymers and the long degradation lifespan of 
PCL was not needed. In addition, when applied to high loading applications, 
being inherently a polymer, PCL was unable to provide sufficient mechanical 
strength. However, following the birth of tissue engineering, PCL has been 
investigated widely due to its superior rheological and viscoelastic properties, 
which translated into advantages in material processing [28].  
One should also appreciate the importance and relevance of obtaining 
regulatory approval, as this would enable to biomedical device to benefit many 
patients. In this respect, PCL is a Food and Drug Administration (FDA) and 
Conformite Europeene (CE) approved material. Thus, it would have faster 
access to hospitals and patients. In research, PCL has been used in various 
tissue engineering applications. To study the biocompatibility of PCL in vivo, 
Menci et al. [31] studied the implantation of PCL prepared by a solvent 
evaporation method, into the rat brain. Over the implantation period of nine 
months, no necrosis was observed, indicating the absence of toxicity. In vivo 
work has also been conducted by Yeo et al. [7] by tracking the degradation of 
PCL based scaffolds implanted in the abdomen of rats, and Rai et al. [5] 
following implantation into the mandible of mongrel dogs. Most recently, PCL 
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has been investigated for wound healing applications by Teo et al. [32], 
making use of its high permeability to deliver gentamicin sulphate (GS), a 
commonly used aminoglycoside with antibacterial activity. Other applications 
of PCL are concisely and accurately discussed in Woodruff and Hutmacher 
[28]. 
2.2.1 Medical grade PCL 
The importance of obtaining regulatory approval from governing bodies like 
FDA, CE and HSA cannot be further highlighted. With approval from these 
bodies, patients will stand to benefit earlier. As such, to make PCL relevant to 
clinical translation, it is necessary to remove as much impurities as possible. 
PCL obtained from commercial companies like Sigma-Aldrich remain impure, 
and therefore will not be translational. As such, medical grade PCL (mPCL) 
should be considered after initial testing has been done using PCL, to enhance 
the translational component of research. mPCL has been used in a variety of 
research work [4, 33] and there has been no reported differences as compared 
to PCL.  
2.3 Polyhydroxyalkanoates 
Polyhydroxyalkanoates (PHAs) are produced by microorganisms under 
unbalanced growth conditions [34]. In general, PHAs are biodegradable and 
have good biocompatibility, making them suitable materials for tissue 
engineering applications.  
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In the past, PHAs and their composites have been used for the development of 
medical devices such as bone plates and surgical meshes, and also as cartilage 
repair devices and nerve guides. A more detailed review on the applications of 
PHAs can be found in Chen and Wu in 2005 [35].  
Despite the favourable cell-material interactions that PHAs are able to 
provide, one factor that is limiting their widespread usage in the field of tissue 
engineering is their availability, while the other factor would be their 
brittleness. Addressing the former, only a select few in the PHA family are 
produced in sufficient quantity for research, they include: 
polyhydroxybutyrate (PHB), copolymers of 3-hydroxybutyrate and 3-
hydroxyvalerate and 3-hydroxyhexanoate and poly-3-hydroxyoctanoate [35]. 
Research has therefore focussed on using these readily available biomaterials, 
with PHB as the principal focus. With regards to their mechanical properties, 
it was reported in Kumagi et al. that microbial PHB is inherently crystalline 
and brittle [36]. As a result, it was necessary to improve the mechanical 
properties to widen its application.  
From a material point of view in tissue engineering, polymer degradation 
products are important in ascertain host-tissue response upon implantation. By 
establishing the toxicity of PHB and its related members, researchers will be 
better placed to understand the potential in vivo effects of PHB. According to 
Reusch [37], low molecular weight PHB is widely distributed in biological 
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cells, being found in representative organisms of nearly all phyla. Therefore, 
he speculates that PHB, its oligomonomers and monomers are not toxic. 
2.3.1 Poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) 
Poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) (PHBHHx) is one of the 
most commonly used polymers belonging to the PHA family. PHAs are 
generally biodegradable, with good biocompatibility. Of the various members 
in the PHA family, only a select few are available in sufficient quantity for 
research, one of them being PHBHHx [38].  
PHBHHx is formed through the copolymerization of polyhydroxybutyrate 
(PHB) and hydroxyhexanoate (HHx). The motivation for copolymerization 
came from the inherent poor mechanical properties of PHB. While PHBHHx 
is not the only copolymer which is PHB-based, other copolymers such as 
polyhydroxybutyrate-co-hydroxyvalerate (PHBV) are not as ductile. Doi et al. 
has summarized the physical properties of PHB, PHBV with different 
hydroxyvalerate (HV) composition, and PHBHHx with different 
hydroxyhexanoate (HHx) composition in a table, and is shown below: 
Table 1 Physical properties of PHB and its copolymers PHBV and PHBHHx in various copolymer 
compositions. Modified from Doi et al. [39].  





PHB 177 4 43 5 
P(HB-co-10% HV) 150 - 25 20 
P(HB-co-20% HV) 135 - 20 100 
P(HB-co-10% HHx) 127 -1 21 400 




From Table 1, it can be seen that PHBHHx is able to provide significant 
improvement in elongation at break, with at least four times improvement over 
PHBV and eighty times improvement over PHB. The ease of processing of a 
material is dependent on the glass transition temperature; lower Tg indicates 
better processing ability. Therefore, PHBHHx in its various HHx 
compositions has also shown enhanced processability with a reduction in Tg.  
To establish the credentials of PHBHHx for use in tissue engineering, it is 
prudent to determine the toxicity of its degradation products. Martin et al. [40] 
showed that hydroxyacids are able to provide nutritional or therapeutic 
compositions of ketone bodies. Therefore, it appears that hydroxyacids 
(hydroxyhexanoate) are non-toxic, and might even have nutritional value to 
the body.  
PHBHHx has been investigated for its responses to many different cell types, 
including human mesenchymal stem cells (MSCs) [41], bone marrow-derived 
stem cells (bmSCs) [42], human adipose-derived stem cells (ADSCs) [43], 
smooth muscle cells (SMCs) [44], human umbilical vein endothelial cells 
(HUVECs) [45], and neural stem cells (NSCs) [46]. In addition, in vivo work 
(subcutaneous implantation in rabbits) [47] has shown that PHBHHx was very 
inert, as indicated by the thinnest surrounding capsule consisting of fibers and 
fibroblast. It reported only 10% of weight loss over the implantation period of 
6 months, slower than that of PLA. Its degradation products also elicited mild 
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tissue response, cementing its credentials for use in the field of tissue 
engineering.  
The use of hMSCs on PHBHHx and PHBHHx-based membranes has been 
reported in literature recently [53-61]. In Wei et al. [54], PHBHHx was one of 
the films studied in the investigation of bone marrow-derived MSCs, and was 
found to enhance proliferation of MSCs as compared to PLA and tissue 
culture plates. In addition, by culturing PHBHHx with MSCs in osteogenic 
induction medium and staining using von Kossa and alkaline phosphatase 
(AP), hMSCs on PHBHHx films showed differentiation into osteoblasts. This 
result suggested the possibility of hMSCs differentiating into osteoblasts on 
PHBHHx films. Biocompatibility of PHBHHx with hMSCs was studied by 
Hu et al. [61] and it was found from their work that PHBHHx were 
biocompatible with hMSCs, with AP and von Kossa staining showing the 
differentiation of MSCs into osteoblasts 3 weeks into culture in osteogenic 
inducing medium. 
It has been reported in literature that the osteogenic potential of hfMSCs as 
compared to hMSCs is much higher [10]. In this work by Zhang et al., 
hfMSCs were seeded onto PCL-TCP scaffolds and were found to have the 
greatest osteogenic capacity than MSCs from human fetal bone marrow, 
human umbilical cord, and human adipose tissue. In addition, in vivo work 
showed the most robust mineralization following implantation into 
immunodeficient mice. As such, the osteogenic potential of hfMSCs has been 
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clearly shown in this work, while the ability of PHBHHx to induce early 
proliferation of hfMSCs into osteoblasts has been suggested from literature. 
  
Figure 2 Multiple lineages of hMSCs into bone, cartilage, tendon, ligament, marrow stroma, adipocyte, 
dermis, muscle and connective tissues. Adapted from Caplan et al. [62]. 
 
2.4 PHB/PCL blends and their properties 
Considering that PHBHHx/mPCL will be a relatively new polymer blend prior 
to Katsumata et al.’s publication in 2011 [48], it should however, be noted that 
PHB/PCL have been studied by various researchers. Kumagai and Doi [36] 
investigated the enzymatic degradation and morphologies of a variety of 
binary blends containing PHB, one of them being PCL. Across the blend 
proportions tested, two distinct melting endotherms were noticed, indicating 
that they were immiscible. Further evidence from morphological observations 
revealed that phase separation occurred, resulting in a porous cross section 
when viewed microscopically. It was thus concluded that PHB/PCL was 
immiscible. In 2002, Chee et al. demonstrated that PCL was immiscible with 
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PHB [18] after studying solution viscosity using Flory-Huggins equation. 
They found that the K value, which is the Huggins coefficient, is lower for 
PHB/PCL blends, indicating immiscibility. In 2007, Lovera et al. [22] studied 
the thermal and morphological aspects of PHB/PCL blends. It was found that 
PCL of molecular weight 120,000 g/mol was immiscible with PHB across the 
entire range of blend proportions, exhibiting two distinct melting temperatures 
that were not affected greatly when compared to their pure components. They 
postulated that this could indicate microphase separation of PHB/PCL. In 
addition, they found that the addition of PCL did not affect the spherulitic 
morphology of PHB, and that there was a decrease in PHB nuclei density upon 
addition of PCL.  
2.5 Degradation of PHBHHx and PCL 
Polymer degradation profiles are important in the understanding of relatively 
new and unexplored materials. The degradation of PHBHHx and PHB-based 
blends have been carried out by a variety of researchers [35, 36, 47, 63-66]. 
Wang et al. [64] concluded from their study that surface morphology was 
important in the degradation of PHBHHx, and cited low crystallinity and 
rough surface as the main driving force behind high degradation rate. Kumagai 
and Doi [36] studied the enzymatic degradation of PHB/PCL in an aqueous 
solution of an extracellular PHB depolymerase from Alcaligenes faecalis T1 at 
37oC and a pH of 7.4 , and it was mentioned that there was a complicated 
dependence of PCL weight fraction on the observed rate of enzymatic 
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degradation. Qu et al. [47] studied the  in vivo degradation of PHBHHx and 
PHBHHx blended with poly(ethylene glycol) (PEG), and Mw results revealed 
that a typical bimodal distribution was achieved after 3 to 6 months of 
implantation subcutaneously in rabbits. In addition, an increase in 
polydispersity was recorded, and crystallinity was found to increase from 19% 
to 22% before decreasing, suggesting in their work that degradation occurred 
preferentially in the amorphous regions than the crystalline regions. 
PHBHHx/PEG blends showed accelerated weight loss with smaller Mw 
reduction, suggesting a different degradation mechanism when blended.  
PCL in vivo and in vitro degradations have been well-documented by various 
researchers and our group [67-75]. It has been reported in Vidaurre et al. [71] 
that the enzymatic degradation of PCL using Pseudomonas lipase depended on 
the porosity of PCL cast films, and suggested that degradation took place via 
surface erosion rather than bulk degradation. In addition, it was found that the 
non-dependence on crystallinity indicated that degradation occurred in both 
the amorphous and crystalline regions at the same time, rather than 
preferentially in the amorphous regions. In Lam et al. [74], it was reported that 
there was no Mw changes after 6 months of degradation in vivo and in vitro, 
while there was a minimum mass loss of 1% from PCL scaffolds. In addition, 
crystallinity increased slightly as a result of polymer recrystallization. Lam et 
al. in 2008 reported the accelerated degradation of PCL-based scaffolds in 5M 
NaOH [75]. They found that the degradation pathways for accelerated 
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conditions and simulated physiological conditions using PBS were different, 
with the former following surface erosion pathway while the latter followed 
bulk degradation pathway.  
2.6 Technique for material fabrication 
Solvent casting is a common fabrication technique that has been used widely 
by many researchers [15, 76-83]. The solvent casting of PCL for the study of 
human mesenchymal stem cells (hMSCs) has been done by Guarino et al. 
[78], and noting that the use of toxic solvents could be detrimental to the 
growth of cells, the authors ensured that appropriate time was given for the 
evaporation of solvent from the solution in order to minimize the toxic effect 
of the solvent. Similarly in Yu et al. [80], where hMSCs response to 
topographical cues on PHBHHx films were studied, sufficient time was 
allowed for the evaporation of solvent from the solution to minimize toxic 
effects to cell. As such, with sufficient time to allow for the evaporation of 
solvent to minimize the toxic effects to cells, solvent casting has been proven 





Chapter 3: Materials and Methods 
All materials used in this project have been purchased from Sigma-Aldrich 
unless otherwise stated. Medical grade PCL (mPCL) was purchased from 
Osteopore International, Singapore. PHBHHx was graciously provided by 
Professor Chen Guo-Qiang from Tsinghua University, School of Biomedical 
Sciences and Biotechnology.  
3.1 Fabrication of PHBHHx/PCL films 
A combined mass of 1g of PHBHHx and mPCL was prepared in seven 
proportions (100% PHBHHx/0% mPCL, 90% PHBHHx/10% mPCL, 70% 
PHBHHx/30% mPCL, 50% PHBHHx/50% mPCL, 30% PHBHHx/70% 
mPCL, 10% PHBHHx/90% mPCL, 0% PHBHHx/100% mPCL), and 
dissolved in 100ml of dichloromethane (DCM) at room temperature. The 
solution was stirred for 2h and cast onto Petri dishes with a diameter of 35mm. 
It was allowed to evaporate in a fume hood for 48h under controlled 
evaporation using a uniformly perforated aluminium foil.  
3.2 Mechanical properties  
Mechanical properties were determined by tensile test at room temperature 
conditions. Samples were cut into rectangular strips of 5x1cm2, and each 
individual strip was measured at 6 different points with a micrometer and 
average thickness was calculated. Tensile test was conducted using 
Instron5500 microtester (Instron), with a load cell of 100N and a crosshead 
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speed of 10mm/min. Results presented are mean values of 6 independent 
measurements.  
3.3 Thermal properties  
Thermal properties were evaluated using Differential Scanning Calorimetry 
(DSC) (Shimadzu DSC60). The films were heated from room temperature to 
150oC at a heating rate of 20 K/min to get the first profile and then held at 
150oC for 5mins. They were subsequently cooled at a rate of 10 K/min to 
room temperature, held at 5mins and then re-heated at the same heating rate to 
get the second profile. The test was ended subsequently. 
3.4 Surface morphology—Polarized light microscopy  
Polarized light microscopy (PLM) images were used to investigate the 
microstructure of the films. The films were pressed between two glass slides 
and observed using a Nikon microscope (Optishot-POL). Images were taken 
using an attached Olympus camera using a fixed focal length. Magnifications 
were fixed at 100X and 400X, and images were representative of the entire 
surface of the film. 
3.5 Surface morphology—Field emission scanning electron microscopy  
Field emission scanning electron microscopy (FESEM) (Hitachi S-4300) was 
used to investigate morphology of the films. The films were coated using gold 
sputtering for 30s at 10mA using a gold coater (JEOL JFC-1200) prior to 
loading into the SEM chamber. An acceleration voltage of 10kV was used. 
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3.6 Molecular weight analysis 
Gel permeation chromatography (GPC) was performed by Supramolecular 
Biomaterials Lab (National University of Singapore, Singapore) using a 
Shimadzu SIL-10A and LC-20AD system equipped with two Phenogel 5μ 100 
and 10000Å columns (size: 300 x 4.6 mm) connected in series and a Shimadzu 
RID-10A refractive index detector. A solution of each sample was prepared 
using tetrahydrofuran (THF) as a solvent. 1.5ml THF was added to between 
5mg and 6mg of the sample and at least 30mins was allowed to dissolve the 
sample completely. The solutions were then thoroughly mixed and filtered 
through a 0.45μm phobic PTFE filter. The mobile phase flow-rate used was 
0.3 ml/min at a temperature of 40oC. The data was collected and analyzed 
using LCsolution 1.22 software (Shimadzu). The weight average molecular 
weight (Mw) and number average molecular weight (Mn) of the PCL were 
calibrated using mono-dispersed polystyrene standard samples. 
3.7 Water contact angle 
Surface wettability was determined using sessile drop method on a goniometer 
(VCA Optima). 1μL of distilled water was used. Static water contact angle 
(WCA) was measured 10s after the drop had successfully been made. 
3.8 Degradation studies 
Degradation studies were conducted over a 14 day period in accelerated 
conditions. Samples were cut into uniform dimensions of 3x2 cm2 and 
subsequently immersed in 37oC, 0.5M of sodium hydroxide (NaOH). At 
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stipulated time-points, samples were retrieved and characterized for their 
changes in (a) mass using mass balance with an accuracy of ±0.1mg 
(RADWAG), (b) thermal properties, (c) surface morphology using SEM and 
polarized light microscopy and (e) molecular weight using GPC. 
3.9 Cell source 
Chan and co-workers [49, 50] have reported on the potential of human fetal 
mesenchymal stem cells (hfMSCs). They have shown that hfMSCs are true 
multipotent cells with greater self-renewal and differentiation capacity than 
human MSCs (hMSCs) [50] (Fig. 2). In Chong and Chan [51], the advantages 
of hfMSCs over human hMSCs were also mentioned, such as hfMSCs having 
higher proliferation speed, undergo more population doublings, and 
demonstrate greater plasticity than hMSCs. In addition, there was no immune 
rejection when an allogeneic hfMSC source was injected into a human foetus 
with skeletal dysplasia [52]. hfMSCs thus present as a good cell source with 
its multipotency and enhanced proliferation speed and non-immunogenic.  
hfMSCs (Passage 6) were isolated as previously described in [35-37]. Cells 
were seeded on a flask (75ml, Nunc, Rochester, NY) with a cell density of 
106/ml in DMEM (10% Foetal Bovine Serum/1% Penicillin-Streptomycin). 
Non-adherent cells were removed with the first medium change on day 3. 




Cytocompatibility studies were conducted as described earlier in [84]. Briefly, 
samples of PHBHHx/PCL were attached to 12mm diameter glass coverslips 
using silicone gel. Samples were rinsed and disinfected by soaking in 70% 
ethanol and washed with Phosphate Buffer Saline (PBS) prior to use. 10, 000 
cells/cm2 were seeded onto the samples and they were retrieved at days 3 and 
7 post-seeding for viability assays using fluorescein diacetate/propidium 
iodide (Life Technologies) (FDA/PI). Fluorescent images were obtained by 
confocal laser scanning microscopy (CLSM) (Olympus FV-1000).  
3.11 Statistical analysis 
Results presented in this work were tested for statistical significance using 





Chapter 4: Results  
4.1 Fabrication of PHBHHx/mPCL films 
PHBHHx/mPCL films were successfully fabricated using solvent casting. A 
perforated aluminium foil was used to control the evaporation rate of DCM.  
4.2 Mechanical properties 
 
Figure 3 Stress-strain curves of various PHBHHx/mPCL blends. Overall ductility was improved with 
the addition of mPCL to PHBHHx. Yield strength was maintained in PCL-dominant blend proportions. 
Yield point was taken at the maximum point on the stress-strain curves (as indicated by the arrow), 





















mPCL 10.5 ± 0.8 240.1 ± 32.5 0.29 ± 0.04 --- 
90% PHBHHx/10% 
mPCL 7.7 ± 1.0 185.4 ± 18.7 0.59 ± 0.10 2.05 
70% PHBHHx/30% 
mPCL 7.9 ± 0.3 190.9 ± 22.8 0.47 ± 0.08 1.63 
50% PHBHHx/50% 
mPCL 7.7 ± 0.5 219.9 ± 7.0 0.14 ± 0.04 0.49 
30% PHBHHx/70% 
mPCL 12.2 ± 0.5 284.9 ± 8.9 0.68 ± 0.08 2.39 
10% PHBHHx/90% 
mPCL 11.1 ± 1.5 264.3 ± 19.3 0.58 ± 0.02 2.02 
0% PHBHHx/100% 
mPCL 12.2 ± 0.8 324.6 ± 41.8 0.68 ± 0.10 2.39 
 
 
Figure 4 Yield strain of various PHBHHx/mPCL blends. 30% PHBHHx/70% mPCL showed high yield 
strain (p<0.05). Results were presented as mean ± standard deviation, with between 4-6 independent 
readings for each PHBHHx/mPCL blend. 
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The values of stress and strain were calculated as such: yield stress was 
defined as the maximum point on the stress-strain curve (as indicated by the 
arrow), while yield strain was the corresponding strain value at yield stress. 
Failure strain was defined as the strain at failure, while the Young’s modulus 
was calculated using a secant modulus due to the non-linear nature of the 
elastic region. From Table 2, 100% PHBHHx/0% mPCL presented 
comparatively lower yield strength than 0% PHBHHx/100% mPCL. When 
small amounts of mPCL was added to 100% PHBHHx/0% mPCL, yield stress 
decreased to 7.7 MPa and remained around that value until 50 wt% mPCL 
(50% PHBHHx/50% mPCL). Upon further addition of mPCL to 
PHBHHx/mPCL (30% PHBHHx/70% mPCL, 10% PHBHHx/90% mPCL), 
yield strength improved (p<0.05) and remained comparable to 0% 
PHBHHx/100% mPCL (p>0.05). 
The trend for yield strain presented similar findings. As with yield stress, the 
yield strain decreased as mPCL was added to 100% PHBHHx/0% mPCL, and 
no significant changes were found until 50% PHBHHx/50% mPCL. Addition 
of more mPCL to the PHBHHx/mPCL blend resulted in an improvement in 
yield strain at both 30% PHBHHx/70% mPCL and 10% PHBHHx/90% mPCL 
(p<0.05). The graph of modulus showed an expected trend that correlated 




4.3 Thermal properties  
 
Figure 5 Representative DSC profiles (first scan) of PHBHHx/mPCL blends. The melting peaks of both 
PHBHHx and mPCL could be observed in all blends. 
 
 
Table 3 DSC analysis of various PHBHHx/mPCL blends.  
Blend composition Xc (%) 
 PHBHHx component  mPCL component 
 Tm (oC) ΔHm (J/g)  
Tm 
(oC) ΔHm (J/g) 
100% PHBHHx/0% 
mPCL 12.1  95.4 17.8  - - 
90% PHBHHx/10% 
mPCL 13.3  93.4 18.5  60.2 0.9 
70% PHBHHx/30% 
mPCL 11.9  95.6 7.7  60.7 9.1 
50% PHBHHx/50% 
mPCL 25.4  97.3 7.9  62.8 27.3 
30% PHBHHx/70% 
mPCL 31.7  97.6 3.0  63.3 40.3 
10% PHBHHx/90% 
mPCL 27.1  96.1 2.6  62.5 34.5 
0% PHBHHx/100% 






Figure 6 Comparison between the experimental values for Xc and the theoretical values for Xc. It could 
be seen from the graph that there was no similarities between the two profiles apart from 50% 
PHBHHx/50% mPCL and 30% PHBHHx/70% mPCL. 
 
The thermal properties investigated using DSC analysis revealed the inherent 
immiscibility of PHBHHx/mPCL blends. Two melting peaks were observed 
throughout all blend proportions (Table 3 and Fig. 5), indicating insufficient 
interaction between the two components to result in miscibility. The melting 
temperature of mPCL increased as more mPCL was added to the blend 
(observed from the shift to the right of the melting point of 0% 
PHBHHx/100% mPCL indicated by the vertical dotted line). Measurement of 
crystallinity was calculated by taking the summation of individual 
component’s crystallinity as shown in the following equation, 
Xc = ��∆Hm∆HT�PHBHHx + �∆Hm∆HT�mPCL�× 100% 
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Where ∆Hm represents the experimental melting endotherm and ∆HT 
represents the theoretical melting endotherm. Table 3 showed a general 
increasing trend in Xc from upon addition of mPCL, and this trend could be 
better observed in Fig. 6 (bold line). It was noted that in 30% PHBHHx/70% 
mPCL, the crystallinity was high, and the main contributing factor to the high 
crystallinity was the melting endotherm resulting from the mPCL phase. From 
Fig. 6, the theoretical Xc was plotted against the experimental Xc. Although 
the profiles indicated that the experimental Xc did not obey the trend predicted 
by the theoretical model [66], which was calculated based on the proportion of 
PHBHHx and mPCL in the blend as shown in the equation below: 
∆Hm = (∆Hm,𝑃𝐻𝐵𝐻𝐻𝑥 × Γ𝑃𝐻𝐵𝐻𝐻𝑥) + (∆Hm,𝑚𝑃𝐶𝐿 × Γ𝑚𝑃𝐶𝐿) × 100% 
it could be observed from Fig. 6 that the general trend of Xc did not deviate 





4.4 Surface morphology—Polarized light microscopy  
 
Figure 7 PLM images of various PHBHHx/mPCL blends, taken at 200X magnification. A single colour 
was observed for 100% PHBHHx/0% mPCL, 90% PHBHHx/10% mPCL and 70% PHBHHx/30% 
mPCL while diffraction of light was observed in the rest of the blends. 
 
Spherulites, which are indicative of a crystalline structure, contain both chain-
folded lamellae that radiate outwards from their centre and amorphous regions 
that separate adjacent lamellae. Therefore, we should understand that one 
spherulite does not indicate a region of 100% crystallinity. Instead, it is made 
up of crystalline lamellae structures and amorphous regions. From Fig. 5, it 
can be seen clearly that 100% PHBHHx/0% mPCL does not form obvious 
spherulitic structures as compared to 0% PHBHHx/100% mPCL, which was 
identifiable by the characteristic Maltese crosses. In addition, the presence of 
different colours observable in mPCL indicated the higher Xc of mPCL 
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because only lamellae structures can diffract light and lead to the observation 
of different colours. This was not seen in 100% PHBHHx/0% mPCL films 
which were largely amorphous (12.1%). 
From the images, mPCL spherulites were observed in blends from 50% 
PHBHHx/50% mPCL onwards. At 50% PHBHHx/50% mPCL, it was 
observed that PHBHHx and mPCL both formed agglomerations, with 
PHBHHx forming slightly elliptical structures and mPCL forming spherulitic 
structures, suggesting minimal interaction with each other. 30% 
PHBHHx/70% mPCL and 10% PHBHHx/90% mPCL displayed spherulitic 
structures which appeared to be optically homogeneous. The images also 
suggested that the grain sizes between 30% PHBHHx/70% mPCL, 10% 
PHBHHx/90% mPCL and 0 PHBHHx/100m PCL were different, but there 
was difficulty in taking measurements because PHBHHx and mPCL structures 
were still distinct, as observed from the SEM images in the ensuing section. 
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4.5 Surface morphology—Scanning electron microscopy  
 
Figure 8 Scanning electron micrographs of PHBHHx/mPCL taken at 500x and 200x (inset) 
magnifications. It can be seen that 0% PHBHHx/100% mPCL had larger grain sizes than 100% 
PHBHHx/0% mPCL, and 50% PHBHHx/50% mPCL, 30% PHBHHx/70% mPCL, and 10% 
PHBHHx/90% mPCL all showed that different constituents of PHBHHx and mPCL could be determined 
using SEM.  
 
SEM images taken at 500x and 200x magnifications indicated the 
morphologies of PHBHHx/mPCL blends. It could be seen that 0% 
PHBHHx/100% mPCL had a distinct spherulitic structure that was not 
observable in 100% PHBHHx/0% mPCL. Upon closer observation, 100% 
PHBHHx/0% mPCL formed very small spherulites. It was also observed from 
Fig. 7 that 100% PHBHHx/0% mPCL and 0% PHBHHx/100% mPCL could 
be recognized easily due to their distinct and different morphologies. 
PHBHHx displayed a slightly rounded, globular appearance while mPCL was 
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more polygonal, and had a cobblestone appearance (as indicated by arrows). 
In 30% PHBHHx/70% mPCL and 10% PHBHHx/90% mPCL, the distinction 
between PHBHHx and mPCL could be made due to their distinct 
morphologies described earlier. In 50% PHBHHx/50% mPCL, the boundaries 
of the grains could not be seen clearly but globular and cobblestone 
morphologies could still be observed.  
The grain sizes of 100% PHBHHx/0% mPCL and PHBHHx dominant blends 
were visibly smaller as compared to 0% PHBHHx/100% mPCL and mPCL 
dominant blends. Between 30% PHBHHx/70% mPCL and 10% 
PHBHHx/90% mPCL, the mPCL spherulite sizes were much larger in 10% 
PHBHHx/90% mPCL. The mPCL spherulite sizes in 30 PHBHHx/ 70 mPCL 
were similar to that of 0% PHBHHx/100% mPCL. Pores could be seen in all 
of the blends, and were distributed uniformly throughout the morphologies. 





4.6 Molecular weight analysis 
 Figure 9 Mw profiles of various PHBHHx/mPCL blends. It could be seen that the peak Mw height 
shifted (right) towards the lower Mw range as the amount of mPCL added increased. Single peaks were 
found for 30% PHBHHx/70% mPCL and 10% PHBHHx/90% mPCL (as indicated by arrows).  
 
Table 4 Mw, Mn and polydispersity index of various PHBHHx/mPCL blends. It was seen that Mw and 
Mn both decreased with addition of mPCL. 
Blend proportion Mw (g/mol) Mn (g/mol) Polydispersity index 
100% PHBHHx/0% 
mPCL 266926 ± 14593 187767 ± 29919 1.43 ± 0.15 
90% PHBHHx/10% 
mPCL 249214 ± 9993 153450 ± 23802 1.64 ± 0.19 
70% PHBHHx/30% 
mPCL 217637 ± 8238 121676 ± 23329 1.81 ± 0.28 
50% PHBHHx/50% 
mPCL 189231 ± 2932 99225 ± 5504 1.91 ± 0.14 
30% PHBHHx/70% 
mPCL 148793 ± 13936 82896 ± 8233 1.80 ± 0.20 
10% PHBHHx/90% 
mPCL 159436 ± 7085 83633 ± 12273 1.92 ± 0.18 
0% PHBHHx/100% 
mPCL 117606 ± 694 66857 ± 3572 1.76 ± 0.08 
 
GPC results summarized in Table 4 showed that 100% PHBHHx/0% mPCL 
had the highest molecular weight (Mw) of 266926 ±14593 g/mol while 0% 
PHBHHx/100% mPCL showed the lowest Mw of 117606 g/mol. Similar 
observations were obtained by comparing their molecular number (Mn). 
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Expectedly, Mw and Mn both decreased as more amounts of mPCL were added 
to the blend due to its lower Mw and Mn. The polydispersity index (Mw/Mn), n, 
of the blends ranged from 1.43 to 1.92. This distribution was reasonably tight, 
with Mw profiles indicating a reasonably small Mw distribution (Fig. 9). From 
Fig. 9, a gradual shift towards a lower Mw could be observed as the amount of 
mPCL in the blend increased, due to its lower Mw (117606 ± 694 g/mol) . In 
addition, with the addition of mPCL, the peak which was representative of 
mPCL Mw became more intense. In addition, it was noticed that there were 
consistently 2 peaks observed in blends with less than 50% mPCL added. In 
the blends of 30% PHBHHx/70% mPCL and 10% PHBHHx/90% mPCL, only 
one peak was observed (as indicated by the arrows in Fig. 9), which could be 
due to the low amount of mPCL present, obscuring the true peak that was 




4.7 Water contact angle 
Table 5 Water contact angle measurements of various PHBHHx/mPCL blends. WCA is indicative of 
cell attachment preference onto the film surface.  
Blend composition Water contact angle (o) 
100% PHBHHx/0% mPCL 89.2 ± 3.8 
90% PHBHHx/10% mPCL 90.1 ± 3.5 
70% PHBHHx/30% mPCL 84.0 ± 3.5 
50% PHBHHx/50% mPCL 86.6 ± 1.8 
30% PHBHHx/70% mPCL 86.5 ± 4.2 
10% PHBHHx/90% mPCL 75.8 ± 2.3 
0% PHBHHx/100% mPCL 73.3 ± 2.1 
 
WCA is indicative of the wettability of the material surface, with a smaller 
angle indicating better wettability. WCA results in Table 3 showed that both 
100% PHBHHx/0% mPCL and 0% PHBHHx/100% mPCL displayed 
hydrophobic surfaces, with 0% PHBHHx/100% mPCL being slightly more 
hydrophilic (73.3o) than 100% PHBHHx/0% mPCL (89.2o). The addition of 
mPCL resulted in a decreasing trend in WCA, which was an expected result. 
Small standard deviations suggested that the surface wettability was consistent 
throughout the surface of the films. 
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4.8 Degradation studies 
4.8.1 Mass loss 
 
Figure 10 Mass loss of various PHBHHx/mPCL blends over a period of 14 days in 0.5M NaOH. Mass 
loss was normalized against surface area of the PHBHHx/mPCL films. 
 
Fig. 11 shows the mass loss (normalized against surface area) of various 
PHBHHx/mPCL films over the 14 day degradation time. From the 
degradation profile, it could be observed that the degradation profile of 100% 
PHBHHx/0% mPCL was different from that of 30% PHBHHx/70% mPCL 
and 0% PHBHHx/100% mPCL in terms of the rate of degradation. 100% 
PHBHHx/0% mPCL displayed an approximately linear rate of degradation 
over the first 168h of degradation (day 7), and the rate decreased from 168h to 
336h (day 7 to day 14). The degradation profiles of 30% PHBHHx/70% 
mPCL and 0 PHBHHx/100m PCL were similar, with the major differences 
occurring in the initial rate of degradation. The degradation rate of 30% 
PHBHHx/70% mPCL was higher over the first 3 days compared to 0% 
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PHBHHx/100% mPCL and plateaued between 72h and 120h (day 3 and day 
5). There was a second plateau in the rate of degradation of 30% 
PHBHHx/70% mPCL between 168h and 336h (day 7 and day 14), which was 
similar to 0% PHBHHx/100% mPCL. The degradation of 0% PHBHHx/100% 
mPCL was insignificant over the first 72h (3 days) before increasing, and 
plateaued between 120h and 336h (day 5 and day 14). At the end of 336h (day 
14), the mass loss/surface area of 100% PHBHHx/0% mPCL was the highest, 
at 4.6 ± 1.0 mg/cm2, while that of 30% PHBHHx/70% mPCL and 0% 




4.8.2 Molecular weight 
 
Figure 11 Molecular weight distribution curves of various PHBHHx/mPCL blends. (A) 100% 
PHBHHx/0% mPCL Mw distribution widened slightly with increase in degradation time, and shifted 
towards the lower Mw (right, indicated by arrow) (B) 30% PHBHHx/70% mPCL Mw distribution 
widened slightly with increase in degradation time, and a peak indicating smaller Mw appeared from day 
5 (arrows). (C) 0% PHBHHx/100% mPCL Mw distribution widened slightly with increase in degradation 




Figure 12 Mw changes over the degradation period. It could be seen that 100% PHBHHx/0% mPCL 
showed a general decreasing trend, while that of 0% PHBHHx/100% mPCL remained similar to the 
initial value. 30% PHBHHx/70% mPCL showed a decrease in Mw during between 72h (day 3) and 168h 
(day 7), and remained similar after 168h (day 7). 
 
 
Figure 13 Polydispersity index (n) variation of various PHBHHx/mPCL films with respect to 
degradation time. The general trends were similar in all tested films, with all of them following a similar 
trend in Mw/Mn distribution. 
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From Fig. 11, the Mw distribution of 100PHBHHx/0 mPCL (Fig. 11A) showed 
that as degradation time increased, the peak Mw with the highest intensity 
shifted towards the right (as indicated by the arrow) from day 5, suggesting 
that there was a distribution of Mw into different, smaller Mw. This smaller Mw 
peak became more intense towards day 14 of degradation as it was observed to 
become higher. For 0% PHBHHx/100% mPCL (Fig. 11C), it was observed 
that the Mw peak remained consistently around the initial value (117606 ± 694 
g/mol)there was an observable, smaller Mw peak indicative of a smaller Mw 
from day 5. This peak continued to be present until day 14, and there was a 
slight increase in intensity as the degradation time increased. For 30% 
PHBHHx/70% mPCL (Fig. 11B), it was observed that as the degradation time 
increased, the main Mw peak remained similar (148793 ± 13936 g/mol), but a 
smaller peak (indicated by the arrows) was observed from day 5, and this peak 
remained there until day 14.  
Fig. 12 illustrates the trends in Mw changes over the degradation period. It was 
observed that in the case of 100% PHBHHx/0% mPCL, the Mw decreased 
over time, and the Mw at day 14 (226189 ± 218807 g/mol) was smaller in 
value than that on day 0 (266926 ± 14593 g/mol) (Appendix D) (p>0.05). In 
the case of 0% PHBHHx/100% mPCL, the Mw was found to be similar 
throughout the degradation period, with the trend indicating a relatively flat 
profile. This suggested that there were no large changes in the Mw. For 30% 
PHBHHx/70% mPCL, a decrease in Mw was observed between 72h (day 3) 
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and 168h (day 7) (p<0.05). There were no observable changes in Mw between 
day 7 and day 14. 
The polydispersity index (Mw/Mn), n, over the degradation period was shown 
in Fig. 13. It was observed that there were generally two instances where n 
increased, on day 3 and day 7, suggesting that there was a widening in the 
distribution of the Mw profile, which could be observed from Fig. 13. This 
suggested that there were changes in Mw, possibly to a lower value, resulting 






4.8.3 Thermal properties 
 
Figure 14 Xc changes over the degradation period, of various PHBHHx/mPCL films.  
 
The changes in Xc were recorded over the degradation period of 336h (14 
days) by DSC. It could be observed from Fig. 15 that the Xc of 100% 
PHBHHx/0% mPCL decreased over time, from an initial value of 12.1% to a 
final value of 6.5% (Appendix C, Table C1). The Xc of 0% PHBHHx/100% 
mPCL increased over time until 62.2% from an initial value of 44.2% 
(Appendix C, Table C1). The trend for 30% PHBHHx/70% mPCL was 
different, with an initial increase over the first 168h to 58.7%, before 
decreasing to 51.6% at the end of the degradation period. 
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4.8.4 Polarized light microscopy 
 
Figure 15 PLM images of various PHBHHx/mPCL films at days 3, 5, 7 and 14 of degradation period. 
Gradual degradation of the spherulitic structure could be observed as degradation time increased.  
 
From the PLM images shown in Fig. 16, it can be seen that as the degradation 
time increases, there is no observable change in the coloration depicted by 
100% PHBHHx/0% mPCL. For 0% PHBHHx/100% mPCL, the spherulitic 
structure remains clear throughout the degradation period, although blurring of 
the inter-spherulite boundary could be observed. On day 14, spherulitic 
boundaries appeared to widen. For 30% PHBHHx/70% mPCL, the spherulitic 
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structure remained intact until day 14, where observable blurring of the inter-
spherulitic boundaries could be observed.  
4.8.5 Scanning electron microscopy 
 
Figure 16 SEM images (800X magnification) of PHBHHx/mPCL films that were subject to degradation 
over a period of 14 days in 0.5M NaOH. Scale bar represents 20μm. 
 
From Fig. 17, it could be seen that as degradation time increased, the number 
and size of pores increased, and they could be identified by the observation of 
the whitish regions in the SEM images. The morphology of 100% 
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PHBHHx/0% mPCL remained largely similar except for the presence of larger 
pits with increased degradation time. For 30% PHBHHx/70% mPCL, small 
pits could be observed on the film surface from day 3. As the degradation time 
increased, it could be observed that the morphology of PHBHHx in the blend 
became less obvious; in fact, we were unable to identify PHBHHx in the SEM 
pictures after day 5. However, the spherulitic structure belonging to mPCL 
continued to be observed clearly throughout the degradation time. For 0% 
PHBHHx/100% mPCL, degradation was more sever after day 7, where deep 
pits could be observed from the pores, and on day 14, the boundaries between 







Figure 17 CLSM images of hfMSCs cultivated on 0 100% PHBHHx/0% mPCL, 30% PHBHHx/70% 
mPCL, and PHBHHx/100 mPCL films with live/dead staining using FDA/PI. Dead cells (red) were still 
seen on day 3 post-seeding for 100% PHBHHx/0% mPCL films, but day 5 post-seeding revealed that 
hfMSCs had proliferated and cell spreading was more pronounced in all the films. Scale bar represents 
100 μm. 
 
hfMSCs were seeded onto non-surface treated 0% PHBHHx/100% mPCL, 
100% PHBHHx/0% mPCL, and 30% PHBHHx/70% mPCL films. On day 3 
post-seeding, hfMSCs were found to have spread and adhered onto the all the 
films. However, 100% PHBHHx/0% mPCL still showed some dead cells 
(stained in red), but these remain few in number. 30% PHBHHx/70% mPCL 
showed comparatively the best proliferation on day 3. On day 5 post-seeding, 
hfMSCs have increased in number from day 3 post-seeding, and 100% 
PHBHHx/0% mPCL and 30% PHBHHx/70% mPCL continued to show much 
more viable cells. In terms of hfMSC adhesion, results suggested that initial 
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hfMSC adhesion was better on 30% PHBHHx/70% mPCL and 0% 
PHBHHx/100% mPCL films than on 100% PHBHHx/0% mPCL films, 
because hfMSCs began to take on a slightly elongated morphology by day 3 
post-seeding. However, following day 3 post-seeding, it was found that cell 
adhesion was better in 100% PHBHHx/0% mPCL and 30% PHBHHx/70% 
mPCL films than on 0% PHBHHx/100% mPCL films as more hfMSCs were 
observed to take on its characteristic fibroblastic appearance, as observed by 
Donoghue and Chan [49]. Differences in cell morphology suggested that cell 
fate could be different when comparing 0% PHBHHx/100% mPCL films and 
the group of 100% PHBHHx/0% mPCL and 30% PHBHHx/70% mPCL films. 
Chapter 5: Discussion 
This first part of this thesis was to investigate the mechanical properties of 
PHBHHx/mPCL blends, and it was achieved using various characterization 
techniques described in the previous sections. 
5.1 Mechanical properties of PHBHHx/mPCL blends 
The mechanical properties of PHBHHx/mPCL blends were determined using 
tensile testing, and the results were summarized in Table 2, Fig. 3 and Fig. 4.  
Generally (with the exception of 50% PHBHHx/50% mPCL), the failure strain 
of PHBHHx has been enhanced with the addition of mPCL (Table 2, at least 
1.63x, p<0.05), suggesting that ductility, which is a function of stress and 
strain, has also improved. It could be inferred from the stress-strain curves in 
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Fig. 3 that the toughness has also been improved. These improvements in 
ductility and toughness could possibly be due to the addition of mPCL. mPCL 
is known to be a very ductile polymer, and its high ability to be drawn is due 
to its low Tg, which makes it rubbery at room temperature [85]. There has 
been good agreement with this from our work, with 0% PHBHHx/100% 
mPCL showing high toughness (Fig. 3). Therefore, with the addition of a 
polymer with high toughness, the overall toughness and ductility of the blend 
could be improved. 
The yield strains of the various PHBHHx/mPCL blends were also recorded in 
Fig. 4. Summarizing the results, it could be seen that the addition of mPCL 
initially decreased yield strain until 30% PHBHHx/70% mPCL, where high 
yield strain (0.0819 ± 0.004, p<0.05), when compared to other blends, was 
recorded. Yield strain is representative of the events occurring prior to plastic 
deformation. Therefore, during the initial phase of elongation, amorphous 
regions within the film were elongated in the direction of stretch, which 
contributed to the eventual yield strain. In the case of 30% PHBHHx/70% 
mPCL, which was significantly higher than other blend proportions, we 
postulate that during the initial phase of elongation, the presence of 30 wt% of 
PHBHHx and 70 wt% of mPCL were optimum conditions for this to occur. 
This result suggested that the presence of 30 wt% PHBHHx was able to confer 
high yield strain of 100% PHBHHx/0% mPCL (0.085 ± 0.008) to the blend. 
This ability was not present in other blend proportions, suggesting that the 
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optimum amount of PHBHHx to have in the blend was 30 wt%. In addition to 
the largely amorphous PHBHHx, another contributing factor would be the 
amorphous regions within the spherulites of mPCL. Although its effect on the 
yield strain might not be significant, it nevertheless contributed in part to the 
high yield strain observed.  
The yield strengths of the various PHBHHx/mPCL films (Table 2) revealed 
that high yield strength was recorded when at least 70 wt% of mPCL was 
added (30% PHBHHx/70% mPCL and 10% PHBHHx/90% mPCL). The yield 
strengths exhibited by these two blend proportions were found out to be 
similar to that of 0% PHBHHx/100% mPCL. This phenomenon suggested that 
the load-bearing capability of mPCL crystalline regions were not affected by 
the presence of PHBHHx grains. Conversely, this ability was affected in 
blends of 90% PHBHHx/10% mPCL, 70% PHBHHx/30% mPCL and 50% 
PHBHHx/50% mPCL. One possible reason for the observation of such a 
phenomenon could be found in their thermal properties (Table 3). mPCL is a 
comparatively more crystalline polymer (Xc: 46.6%) than PHBHHx (Xc: 
12.1%), thus the lamellae structure is more developed in mPCL. The enthalpy 
of melting ∆Hm in 30% PHBHHx/70% mPCL (40.3 J/g) and 10% 
PHBHHx/90% mPCL (34.5 J/g) were at least half of 0% PHBHHx/100% 
mPCL (63.4 J/g), suggesting that spherulites in those blend proportions were 
comparatively well developed, as compared to 90% PHBHHx/10% mPCL 
(0.9 J/g), 70% PHBHHx/30% mPCL (9.1 J/g) and 50% PHBHHx/50% mPCL 
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(27.3 J/g). Therefore, in providing resistance to tilting of lamellar chain folds 
and the separation of crystalline block segments, which initiates the plastic 
deformation phase, 30% PHBHHx/70% mPCL and 10% PHBHHx/90% 
mPCL would perhaps have higher resistance than the other blend proportions. 
This higher melting endotherm reflected higher Xc for both these blend 
proportions. Higher Xc could be the result of having smaller Mw, as reflected 
by GPC results (Table 4). In 30% PHBHHx/70% mPCL and 10% 
PHBHHx/90% mPCL, the Mw were lower than the other blend proportions, 
suggesting that the ability to fold and pack into crystalline regions would be 
better in these 2 blend proportions. In addition, the smaller Mw of 30% 
PHBHHx/70% mPCL as compared to 10% PHBHHx/90% mPCL also 
suggested that chain packing and folding was more efficient, explaining why 
the Xc of 30% PHBHHx/70% mPCL was higher than that of 10% 
PHBHHx/90% mPCL. 
The Young’s modulus of the various PHBHHx/mPCL films was presented in 
Table 2. The Young’s modulus is related to the degree of crystallinity Xc, with 
increasing Xc implying increasing modulus. By putting the Xc and modulus 
values together (Table 6), experimental results concurred with theoretical 
predictions that a smaller Xc resulted in a lower modulus, while a higher Xc 
led to a higher modulus. This phenomenon could be explained by the 
extensiveness of secondary bonding, which is present when molecular chains 
are packed closely together. When close packing of molecular chain occurs, 
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extensive secondary bonding can take place, resulting in higher Xc and thus 
higher tensile modulus and strength. In amorphous regions, secondary bonding 
is weaker due to chain misalignment and thus lower Xc and lower tensile 
modulus [86].  
Table 6 Xc and modulus of various PHBHHx/mPCL blends. 
Blend composition Xc (%) Modulus (MPa) 
100% PHBHHx/0% mPCL 12.1 240.1 ± 32.5 
90% PHBHHx/10% mPCL 13.3 185.4 ± 18.7 
70% PHBHHx/30% mPCL 11.9 190.9 ± 22.8 
50% PHBHHx/50% mPCL 25.4 219.9 ± 7.0 
30 PHBHHx/70m PCL 31.7 284.9 ± 8.9 
10% PHBHHx/90% mPCL 27.1 264.3 ± 19.3 
0% PHBHHx/100% mPCL 46.6 324.6 ± 41.8 
 
It was mentioned that the mechanical properties of an immiscible polymer 
blend were dependent on phase morphology, interaction, composition, and 
processing history [23, 87]. With that in mind, the SEM results would possibly 
reveal information based on phase morphology. Fig. 8 showed that 100% 
PHBHHx/0% mPCL had a grainy appearance, with many small pores present. 
The formation of pores could be due to either the solvent evaporation process 
or the cyrstallization process in semi-crystalline polymers [20]. In Gao et 
al.[20], these factors were investigated by covering PHBHHx/PDLLA blend 
solutions in chloroform with Petri dish lids during the solvent evaporation 
process to control solvent evaporation. They found that in the case of pure 
PHBHHx, many micropores were found, while no micropores were found on 
PDLLA films. From their thermal analysis results, PDLLA was found to be an 
amorphous polymer, with no observable melting endotherm due to the random 
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distribution of D- or L- chiral carbon in the backbone chain which led to the 
disruption of the formation of regular configuration of polymer chains, 
causing them to be unable to pack and fold into crystal lamellae lattices. 
Therefore, in the case of semi-crystalline polymers, which include PHBHHx 
and mPCL, the evaporation of solvent was not the main factor that led to the 
formation of a surface that was not smooth and flat, and which contained 
pores. According to both Gao et al. [20] and Zhang et al. [44], it is the 
crystallization process during the formation of spherulites that led to the 
creation of internal stresses, and led to the formation of pores.  
From Fig. 8, it could be observed that the size of the pores in 100% 
PHBHHx/0% mPCL and 0% PHBHHx/100% mPCL was different. The size 
of the pores in 100% PHBHHx/0% mPCL was smaller than in 0% 
PHBHHx/100% mPCL. With the understanding that mPCL (Xc: 46.6%) is a 
more crystalline polymer than PHBHHx (Xc: 12.1%), this observation 
suggested that an increase in Xc led to the creation of more internal stresses, 
which led to the formation of larger pores. Therefore, when mPCL was added 
to PHBHHx, it could be seen from Fig. 8 that the size of the pores increased, 
and this phenomenon could be due to the presence of mPCL crystal lamellae 
lattices, which increased the internal stresses due to their inherently higher 
crystallinity and led to the formation of larger pores. From a polymer defect 
point of view, the presence of grain boundaries, which are related to the 
number of pores cause mechanical properties to deteriorate. This has been 
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discussed in detail in Callister [86]. Therefore, based on phase morphology 
using SEM, the results suggested that the mechanical properties of 90% 
PHBHHx/10% mPCL and 70% PHBHHx/30% mPCL would be poorer than 
that of  100% PHBHHx/0% mPCL, and this was reflected in the lower yield 
strength exhibited (Table 2).  
An important piece of information that could be derived from the phase 
morphology would be that PHBHHx/mPCL blends were incompatible 
throughout the blend compositions. In a compatible system, a single 
continuous phase should be observed but in PHBHHx/mPCL blends, distinct 
morphologies of PHBHHx and mPCL could be identified, especially in 30% 
PHBHHx/70% mPCL and 10 PHBHHX/90 mPCL blends (Fig. 8). PHBHHx 
adopted a globular structure while mPCL formed typical polygonal structures. 
The agglomeration of PHBHHx into large globular structures could also be 
observed in the blends of 50% PHBHHx/50% mPCL, 30% PHBHHx/70% 
mPCL and 10% PHBHHx/90% mPCL. This observation led to the postulation 
that interfacial tension was high in PHBHHx/mPCL blends, and interfacial 
tension is a factor that affects the mechanical properties of such a polymeric 
blend. This was brought up in 1988 by Anastasiadis et al. [17]. In a single-
phase material, this factor will probably have little effect on the mechanical 
properties because there is only one component, but in the case of a bi- or 
multi-component system, such as PHBHHx/mPCL, the effect that interfacial 
tension has on the mechanical properties is not trivial. Despite this, it was also 
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mentioned that there could exist a specific composition at which a synergistic 
effect of the components in the system could occur, leading to an enhancement 
in properties. This was known as the “rule of mixtures behaviour” [17]. In the 
immiscible polymer blend system of PHBHHx/mPCL, incompatibilization 
could be observed from SEM images (Fig. 8) and from the PLM images (Fig. 
9). Therefore, these results suggest that interfacial tension is high in 
PHBHHx/mPCL blends, which would lead to poorer mechanical properties. 
However, there was a specific composition at which the mechanical properties 
were generally enhanced, and that was at 30% PHBHHx/70% mPCL. 30% 
PHBHHx/70% mPCL blend was able to combine the high yield strain of 
PHHHHx, the high yield strength and high toughness of mPCL, to result in a 
mechanically more desirable polymeric material. 
Comparing 100% PHBHHx/0% mPCL, 90% PHBHHx/10% mPCL and 70% 
PHBHHx/30% mPCL, it appeared that PHBHHx and mPCL were not clearly 
decipherable although it was mentioned earlier that each had a distinct 
morphology. The mechanism by which crystal growth takes place is 
nucleation and growth. In a situation where a lack of nucleation sites occurs, 
such as when mPCL were in small amounts (10 wt%, 30 wt%), this could 
suggest that the size of the crystals or spherulites formed were possibly either 
small or growth was stunted. As a result, it was possible that the blend 
remained amorphous like 100% PHBHHx/0% mPCL. DSC analysis (Table 3) 
confirmed this postulation, with the mPCL component displaying on an 
54 
 
enthalpy of melting of 0.9 J/g and 9.1 J/g in 90% PHBHHx/10% mPCL and 
70% PHBHHx/30% mPCL respectively, which corresponded to a Xc of 13.1% 
(90% PHBHHx/10% mPCL) and 11.9% (70% PHBHHx/30% mPCL). 
Therefore, it seemed possible that the lack of nucleation sites affected the 
growth and size of mPCL crystals, which led to higher amorphous structure. 
This also reflected a lack of extensive secondary intermolecular bonding and 
resulted in poorer mechanical properties.  
To address the anomaly exhibited by 50% PHBHHx/50% mPCL, in which 
overall ductility and toughness decreased (Fig 2) and mechanical properties 
were poorer despite high crystallinity (Table2 and Table 3), one possible 
reason could be due to the high degree of phase separation, which could be 
observed clearly from PLM images (Fig. 7). The SEM images (Fig. 8) did not 
allow for the easy identification of PHBHHx and mPCL phases, but under 
cross-polarized light, where crystal lamellae structures have different optical 
properties from amorphous structures, this identification was clear and direct. 
50% PHBHHx/50% mPCL displayed clear, large agglomeration of PHBHHx 
into globular structures (reddish tint) while mPCL remained spherulitic, 
identifiable by the characteristic Maltese cross. It could be that the large 
agglomerations of PHBHHx increased the interfacial tension, which then 
affected its mechanical properties. However, more work will have to be done 
in order to account for the poorer mechanical properties of 50% 
PHBHHx/50% mPCL.  
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5.2 Cytocompatibility of PHBHHx/mPCL 
In the development of a relatively new and unexplored biomaterial, it is 
important to understand the interactions of this biomaterial at the cellular 
level. Therefore, cytocompatibility of 100% PHBHHx/0% mPCL, 0% 
PHBHHx/100% mPCL, and 30% PHBHHx/70% mPCL were determined with 
hfMSCs, and the proliferation data were shown in Fig. 10. The results showed 
enhanced proliferation for 30% PHBHHx/70% mPCL and 100% 
PHBHHx/0% mPCL on day 5 post-seeding, while 0% PHBHHx/100% mPCL 
showed lower proliferation.  
Apart from the proliferation ability, it is also important to observe the 
morphology of the hfMSCs because this will be able to give an indication of 
the adhesion of hfMSCs on the various films. There have been various reports 
indicating an optimal range of cell attachment angles, with each research 
group using their own set of polymeric surfaces treated with plasma, corona, 
or surface graft polymerization [88-92]. Despite their differences in polymer 
chemical composition and surface treatment, it was noticed that they shared 
one point in common, that is the cell adhesion to such polymeric surfaces were 
very much dependent on properties like chemical functionalities, wettability 
and surface roughness [93]. Importantly, we believe that surface 
functionalities and wettability could possibly play an important role in the 
cytocompatibility of 100% PHBHHx/0% mPCL, 0% PHBHHx/100% mPCL 
and 30% PHBHHx/70% mPCL with hfMSCs. Surface functionalities include 
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surface functional groups such as methyl, hydroxyl, carboxylic acid, or amino 
terminal functional groups [94]. 
Cell adhesion is the binding of a cell to a surface using cell adhesion 
molecules such as selectins, integrins, and cadherins [95]. The critical factor in 
determining the interaction between the cell and the material surface would 
then be its surface properties, which can be and was determined by water 
contact angle testing. From the results shown in Table 5,it could be observed 
that 100% PHBHHx/0% mPCL, 30% PHBHHx/70% mPCL and 0% 
PHBHHx/100% mPCL had slightly different values for water contact angle, 
but were generally hydrophobic (>70o). Such hydrophobic surfaces have been 
reported to be non-optimal for cell adhesion; water contact angle values in the 
range of 40-70o were reported to be better for cellular adhesion [88-92, 96]. 
However, despite the lack of optimal surface wettability for cell adhesion, it 
could be seen that on day 3, hfMSC attachment on all three films was still 
possible. By observing the distribution of the cells on day 3, it was found that 
distribution of hfMSCs on 0% PHBHHx/100% mPCL films were uniform, 
while distribution on 30% PHBHHx/70% mPCL films were slightly 
aggregated. This observation was similar to Yu et al., where hMSC 
aggregation was observed on cast PHBHHx membranes after 9 days post-
seeding [97]. In our work, cell aggregation was observed on day 3 post-
seeding, primarily due to the higher cell seeding density. Although it is 
unknown why cell aggregation might occur, it has been reported that there are 
57 
 
two competing effects: the interactions between cells and the substrate and the 
interactions between cells [98]. With a higher cell seeding density in our work, 
the cell-cell interaction distance could have become shorter and possibly led to 
easier cell aggregation, thus earlier cell aggregation was observed. 
After cell adhesion, the proliferation potential of the various films was 
investigated. The results suggested higher proliferation potential of 30% 
PHBHHx/70% mPCL and 100% PHBHHx/0% mPCL than 0% 
PHBHHx/100% mPCL, which could possibly suggest that the affinity of 
hfMSCs on PHBHHx films was higher than mPCL films. This could be, in 
part, due to the functional groups attached on PHBHHx as compared to PCL 
(Fig. 18). The separation between neighbouring carbonyl groups which are 
mainly responsible for the wettability characteristics of PHBHHx and mPCL 
could affect the proliferation ability of the hfMSCs, although there still 
remains much work to be done in this respect. Another possibility that could 
lead to the higher proliferation of hfMSCs on 30% PHBHHx/70% mPCL 
would be the membrane morphology, as shown in Fig. 7 and 8. It could be 
seen that with smaller grain sizes in 30% PHBHHx/70% mPCL, the 
undulating nature of the surface led to the higher initial adhesion of hfMSCs. 
Furthermore, our results have suggested that the presence of PHBHHx could 
be responsible for the higher proliferation capacity of hfMSCs.  
Importantly, the preliminary results here suggest that the biocompatibility of 
30% PHBHHx/70% mPCL has not been compromised with the addition of 
58 
 
mPCL to 100% PHBHHx/0% mPCL, which is crucial in the development of 
biomaterials.  
 
Figure 18 Illustration of the chemical structure of (A) PHBHHx and (B) mPCL. Adapted from Zhang et 
al. [99] and Polysciences, Inc. [100] respectively.  
 
5.3 Degradation studies  
Degradation studies were carried out to understand the effects of polymer 
blending on the degradation of PHBHHx/mPCL. mPCL is a biodegradable 
polymer that has a long lifespan [28, 74, 101-103], and the main functional 
group in mPCL would be the ester linkages that would participate in the 
hydrolysis of mPCL. In the structure of PHBHHx, ester linkages are also 
present, and would thus be responsible for its hydrolysis. PHBHHx however, 
being more amorphous than mPCL (Table 3) would probably be more 
susceptible to degradation than mPCL. This postulation was confirmed by 
tracking the mass loss/surface area over a period of 336h (14 days). From Fig. 
11, it could be seen that the increase in mass loss/surface area increased in a 
linear fashion over the first 168h (7 days), suggesting that the degradation rate 
between 0h and 168h was linear. This degradation rate decreased towards the 
end of the degradation period. In a semi-crystalline polymer, regions of crystal 
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lamellae structures exhibit extensive secondary bonding, therefore requiring 
more energy in order to break up these bonding forces and to destroy the 
crystal structure. However, for the amorphous regions, such extensive 
secondary bonding does not exist. Therefore, less energy would be required to 
effect degradation.  
There are mainly two kinds of degradation mechanisms by which the 
degradation of PHBHHx/mPCL blends could proceed by, namely surface 
erosion and bulk degradation, both of which have been shown in Fig. 18 
adapted from Woodruff and Hutmacher [28]. In surface erosion, hydrolytic 
cleavage of the polymer backbone occurs only at the surface, and does not 
lead to a decrease in Mw, but mass loss can be recorded. For bulk degradation, 
water is able to penetrate into the polymer bulk, and hydrolysis will occur 
throughout the polymer system (Fig. 19b). Therefore, hydrolytic chain scission 
will occur randomly throughout the entire polymer system and lead to a 
decrease in Mw. In the case of 100% PHBHHx/0% mPCL, appreciable mass 
loss was recorded over the degradation time (Fig. 11), while lowering of Mw 
was also recorded (Fig. 12). These results suggested that the mechanism by 
which 100% PHBHHx/0% mPCL degraded by was via bulk degradation, 
where water molecules and primarily OH- ions were able to hydrolyze the 
ester linkages and lead to random chain scission. As a result, decrease in Mw 
could be detected.  
60 
 
The degradation of PCL (or PCL in various blend or co-polymer systems) has 
been recorded widely in literature by various groups of researchers [67-69, 71, 
104-108]. Generally, it is believed that the degradation of PCL in vivo 
proceeds via two stages: the non-enzymatic hydrolytic cleavage of the ester 
groups occurs followed by intracellular degradation which occurs when PCL 
has become highly crystalline and of low Mw (typically less than 3000 g/mol) 
[109]. The first stage of degradation of PCL has been said to be identical to in 
vitro hydrolysis at 40oC, as mentioned by Woodward et al. [109].  
 
Figure 19 (a) Surface erosion and (b) bulk degradation of degradable polymers. Adapted from Woodruff 
and Hutmacher [28] 
 
In this thesis, 0% PHBHHx/100% mPCL displayed low mass loss/surface area 
and no significant changes in Mw, but a smaller Mw peak at around 2900 g/mol 
appeared from day 5 of the degradation period. A similar result was reported 
in Lam et al. [75] in 2008, where PCL scaffolds in 5M NaOH were found to 
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have a smaller Mw peak after 4 weeks of degradation. In their work the mass 
loss of PCL scaffolds decreased after the appearance of the smaller Mw peak, 
which was found to be similar in this thesis, where the rate of mass loss also 
decreased after the appearance of the smaller Mw peak at day 5. These results 
suggested that 0% PHBHHx/100% mPCL degraded via the surface erosion 
mechanism, since no changes in Mw were recorded and only mass loss was 
recorded (thinning). The effect of thinning could be observed from SEM 
images (Fig. 17), where observable pits and removal of mPCL could be 
identified. The changes in Xc of 0 PHBHH/100 mPCL increased over the 
degradation time, from an initial value of 46.6% to a final value of 62.2%. 
This increase in Xc was also recorded in Lam et al. [75], with PCL scaffolds in 
their work attaining a Xc of about 77% from an initial value of about 60%.  
The degradation of 30% PHBHHx/70% mPCL could be divided into three 
stages: from 0h to 72h, followed by 72h to 168h and finally 168h to 336h. 
During the first stage from 0h to 72h, Mw remained the same while Xc 
increased yet mass loss increased, which might seem counterintuitive. 
However, observation of SEM images (Fig. 17) showed that the interfaces 
between PHBHHx and mPCL became much more apparent than at 0h (Fig. 8), 
suggesting that the mass loss was due to the removal of amorphous regions of 
both PHBHHx and mPCL. As a result of the removal of amorphous regions, 
the Xc increased. The mechanism of degradation for this stage could be a 
combination of surface erosion and bulk degradation. 
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In the second stage of degradation from 72h to 168h, there was a smaller 
increase in Xc (approximately 3%), Mw decreased and plateaued while mass 
loss plateaued before increasing. During this stage of degradation, it was 
possible that the increase in mass loss was due to the gradual removal of 
PHBHHx, as it was discovered earlier that PHBHHx was not very resistant to 
hydrolytic cleavage (Fig. 11 and Fig. 13). As a result, the increase in 
crystallinity could be attributed mainly to the increase in crystallinity of 
mPCL, which displayed an increase in the melting endotherm from 70.2 J/g to 
72.1 J/g (Appendix B, Table B1). SEM images also suggested the gradual 
removal of PHBHHx from 30% PHBHHx/70% mPCL blend because 
PHBHHx could no longer be clearly identifiable (Fig. 17). Although the Mw 
decreased during this stage, the highest intensity Mw peak remained close to 
the original value (Fig. 12), suggesting that the decrease in Mw was minor. In 
this second stage of degradation, bulk degradation could be the main 
mechanism. 
In the final stage of degradation from 168h to 336h, the Xc of 30% 
PHBHHx/70% mPCL decreased, Mw and mass loss remained unchanged. In 
this stage of degradation, the crystal structure that was prevalent previously 
had begun to be destroyed. This could be observed from PLM (Fig. 16) 
images. PLM images give a clear indication of the presence of lamellae 
structures as these structures diffract light differently. It could be observed 
from these images that from 168h (day 7) to 336h (day 14), there was a clear 
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distortion of the crystal structure, and less colours were observed. These 
images suggest that the crystal structure in 30% PHBHHx/70% mPCL has 
gradually been destroyed. SEM images (Fig. 17) showed homogeneous 
degradation on the film surfaces, with no observable differences between 168h 
and 336h. Both images displayed extensive degradation with whitish pits 
distributed homogeneously. This stage of degradation could be the initiation 
into the final stage of degradation before the eventual fragmentation of the 
film into smaller pieces. Summarizing the results from the degradation studies 
suggested that 30% PHBHHx/70% mPCL followed both surface erosion and 
bulk degradation at different phases of the degradation period. 
5.4 PHBHHx/mPCL blend for tissue engineering applications 
The results here which indicated improved mechanical properties despite the 
immiscibility of PHBHHx with its blend component are not the first of its 
kind. It has been shown in other publications that an immiscible blend 
involving PHBHHx can lead to improved mechanical properties [20, 44]. 
Briefly, PHBHHx and poly(d,l-lactide) (PDLLA) were blended at different 
proportions and subsequent thermal analysis showed the two to be immiscible, 
but reported higher elongation at break when compared to unblended PDLLA. 
Immiscible PHBHHx and poly(propylene carbonate) (PPC) were also blended 
in order to improve mechanical properties of PHBHHx for blood vessel tissue 
engineering. Mechanical properties were found to be slightly enhanced by 
blending with PPC, with elongation at break improved by 2011.1% when the 
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blend was PPC-dominant. Therefore, it has been proven in other work that 
enhanced mechanical properties can be achieved despite the blend being 
immiscible. 
Recently, Katsumata et al. [48] reported on the toughening effect of PCL on 
PHBHHx. They have shown in their work that the addition of up to 20 wt% of 
PCL was able to result in a tougher material. They have also worked on cast 
films and showed that the addition of PCL could lead to an increase of 
elongation at break by almost 200%. However, their work focused on the use 
of PHBHHx as energy storage materials and not as biomaterials. Considering 
the use of PHBHHx as a biomaterial for tissue engineering applications, the 
mechanical properties within the elastic range would be more important than 
the overall ductility. As such, this thesis has focused on the improvement 
within the elastic range, although improved ductility was also observed by the 
addition of small amounts of mPCL (Fig. 9). The greatest improvement within 
the elastic range for PHBHHx/mPCL blends occurred at 30% PHBHHx/70% 
mPCL, which reported yield strain of 0.0819 ± 0.004 and high yield strength 
of 12.2 ± 0.5 MPa.  
From the preliminary cytocompatibility data discussed in section 5.2, it could 
be seen that cytocompatibility of 30% PHBHHx/70% mPCL was not 
compromised, which bodes well for the application of 30% PHBHHx/70% 
mPCL to the field of tissue engineering. By using hfMSCs as the cell source, 
we have chosen a cell source that is capable of differentiating into multiple 
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lineages such as bone [10]. In addition, the osteogenic potential of hfMSCs 
has also been clearly demonstrated in various literature works [10, 50]. 
Cytocompatibility results in this thesis suggested the higher proliferation 
capacity of 30% PHBHHx/70% mPCL, coupled with the high ductility and 
toughness and favourable degradation properties, a potential application of 
30% PHBHHx/70% mPCL could be in the field of bone tissue engineering. 
 
 
Chapter 6: Conclusion  
This thesis has successfully blended PHBHHx and mPCL using solvent 
blending. The initiative for this thesis has been the widespread usage of 
polymer blend systems in the field of tissue engineering, and it was 
hypothesized at the start of this thesis that favourable interactions between 
PHBHHx and mPCL could result in a mechanically desirable blend as 
compared to pure PHBHHx.  
The mechanical properties suggested that at specific blend composition of 
30% PHBHHx/70% mPCL, inter-component interactions were sufficient to 
result in synergistic effects on the mechanical properties, which resulted in an 
obvious improvement in ductility, toughness, and most notably, yield strain. 
High yield strength was also recorded in 30% PHBHHx/70% mPCL. As a 
result, 30% PHBHHx/70% mPCL rendered good strength, toughness, and 
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ductility. Phase morphology using PLM and SEM revealed that 30% 
PHBHHx/70% mPCL was an incompatible blend, as was the case with all 
other blend proportions tested in this thesis. 
Cytocompatibility tests using hfMSCs suggested that hfMSCs had a higher 
tendency to adhere and proliferate on 100 PHBHHx /0 mPCL films as 
compared to 0% PHBHHx/100% mPCL films. When hfMSCs were seeded 
onto 30% PHBHHx/70% mPCL films, similar cell proliferation was observed 
as compared to 100% PHBHHx/0% mPCL films, which suggested that 30 
wt% of PHBHHx was sufficient to effect hfMSC preference. Cell morphology 
also suggested different cell fate and function on 30% PHBHHx/70% mPCL 
films, with hfMSCs adopting a spindle-like, fibroblastic-like appearance as 
compared to hfMSCs on 0% PHBHHx/100% mPCL. 
Degradation studies on 30% PHBHHx/70% mPCL films suggested that the 
mechanisms by which degradation proceeds for 30% PHBHHx/70% mPCL 
films included both surface erosion (observed by SEM) and bulk degradation 
at different stages of the degradation. The relationship between Xc, mass loss, 
and Mw was established using 100 PHBHH/0 mPCL and 0 PHBHH/100 
mPCL and applied onto 30% PHBHHx/70% mPCL films. The degradation 
behaviour of 30% PHBHHx/70% mPCL, which was similar to 0% 
PHBHHx/100% mPCL, suggested possible applications of 30% 
PHBHHx/70% mPCL into the field of tissue engineering. 
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By relating the mechanical, degradation and cytocompatibility properties of 
30% PHBHHx/70% mPCL blend to the field of tissue engineering, one 





Chapter 7: Future recommendations  
It is common knowledge among researchers and clinicians the importance of 
having a solvent-less approach to scaffold tissue engineering. As such, other 
fabrication methods such as via melt blending or solid-phase mixing could be 
applied to PHBHHx/mPCL blends. Without the use of toxic solvents, risk to 
patients can be minimized. Furthermore, solid-phase mixing techniques such 
as cryomilling and ambimilling could lead to more intimate interactions 
between PHBHHx and mPCL, resulting in perhaps better compatibilization 
therefore possibly better material performance. These changes in fabrication 
could therefore lead to different degradation profiles and consequently 
different applications into the field of tissue engineering.  
With respect to cell-material interactions, more work can be done to 
investigate the effect that the various types of fabrication of PHBHHx/mPCL 
have on cell-material interaction, by analysing cell metabolic activity, and 
perhaps using differentiation markers to determine cell fate and function. All 
these would give a better understanding of PHBHHx/mPCL blends in vitro. In 
vivo work should also be conducted to determine the actual host-material 
interactions, starting with a mouse model to determine biocompatibility. 
Following that, PHBHHx/mPCL scaffolds should be implanted at target sites 
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Appendix A: Mechanical properties supporting data 
 
A 1 Unpaired Student’s t-test assuming unequal variances conducted to determine significance between 




Table Analyzed Yield stress Table Analyzed Yield strain
Column E 30 PHBHHx/70 mPCL Column E 30 PHBHHx/70 mPCL
vs vs vs vs
Column F 10 PHBHHx/90 mPCL Column F 10 PHBHHx/90 mPCL
Unpaired t test with Welch's correction Unpaired t test with Welch's correction
P value 0.2433 P value 0.0152
P value summary ns P value summary *
Are means signif. different? (P < 0.05) No Are means signif. different? (P < 0.05) Yes
One- or two-tailed P value? Two-tailed One- or two-tailed P value? Two-tailed
Welch-corrected t, df t=1.449 df=3 Welch-corrected t, df t=4.070 df=4
How big is the difference? How big is the difference?
Mean ± SEM of column Ee 12.21 ?0.2384 N=4 Mean ± SEM of column Ee 0.08188 ?0.001875 N=4d
Mean ± SEM of column Fe 11.10 ?0.7300 N=4 Mean ± SEM of column Fe 0.06438 ?0.003870 N=4d
Difference between means 1.112 ?0.7679d Difference between means 0.0175 ?0.0043000
95% confidence interval -1.331 to 3.556 95% confidence interval 0.005563 to 0.02944
R squared 0.4116 R squared 0.8055
F test to compare variances F test to compare variances
F,DFn, Dfd 9.379, 3, 3 F,DFn, Dfd 4.259, 3, 3
P value 0.0986 P value 0.2649
P value summary ns P value summary ns
Are variances significantly different? No Are variances significantly different? No
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Appendix B: Degradation analysis supporting data 
 
B 1 Student’s t-test with unequal variances was conducted to determine changes in Mw between day 0 
and day 14 of 100% PHBHHx/0% mPCL (left) and between day 3 and day 7 of 30% PHBHHx/70% 
mPCL (right).  
 
Table B1 Xc and ΔHm of various PHBHHx/mPCL blends over the degradation period. 









12.1 17.8  - 
30% PHBHHx/70% 
mPCL 31.7 3.0  40.3 
0% PHBHHx/100% 




11.5 16.8  - 
30% PHBHHx/70% 
mPCL 50.7 0.27  68.7 
0% PHBHHx/100% 




8.7 12.7  - 
30% PHBHHx/70% 
mPCL 55.8 6.1  70.2 
0% PHBHHx/100% 




6.1 9.0  - 
30% PHBHHx/70% 
mPCL 58.7 8.3  72.1 
0% PHBHHx/100% 
mPCL 49.8 -  67.7 
Mw Mw
100 PHBHHx/0 mPCL (Day 0 vs. Day 14) 30 PHBHHx/70 mPCL (Day 3 vs. Day 7)
Variable 1 Variable 2 Variable 1 Variable 2
Mean 266925.5 226189 Mean 146838.3 122874.3
Variance 2.13E+08 4.79E+08 Variance 8744805 3209657
Observations 2 2 Observations 3 3
Hypothesized Mean Difference 0 Hypothesized Mean Difference 0
df 2 df 3
t Stat 2.190469 t Stat 12.0048
P(T<=t) one-tail 0.07994 P(T<=t) one-tail 0.000622
t Critical one-tail 2.919986 t Critical one-tail 2.353363
P(T<=t) two-tail 0.159879 P(T<=t) two-tail 0.001244






6.5 9.5  - 
30% PHBHHx/70% 
mPCL 51.6 0.03  70.1 
0% PHBHHx/100% 
mPCL 62.2 -  84.5 
 
Table B2 Mass loss/surface area of various PHBHHx/mPCL membranes 
Time (hours)  0 72 120 168 336 
100% PHBHHx/0% 
mPCL 
Average 0.0 1.6 2.5 3.9 4.6 
Standard deviation 0.0 0.3 0.4 0.3 1.0 
30% PHBHHx/70% 
mPCL 
Average 0.0 0.6 0.5 1.3 1.2 
Standard deviation 0.0 0.2 0.2 0.2 0.6 
0% PHBHHx/100% 
mPCL 
Average 0.0 0.0 0.9 1.2 1.2 
Standard deviation 0.0 0.1 0.2 0.4 0.8 
 
